QURE: Reports Prelim Data
uniQure announces preliminary data on the first cohort in the Phase I/IIa clinical trial of AMT-260 in refractory mesial temporal lobe epilepsy
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.